Global Markets Direct's, 'Vaginal Atrophy (Atrophic Vaginitis) -
Pipeline Review, H2 2012', provides an overview of the indication's
therapeutic pipeline. This report provides information on the
therapeutic development for Vaginal Atrophy (Atrophic Vaginitis),
complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the
therapeutic development for Vaginal Atrophy (Atrophic Vaginitis).

Scope

- A snapshot of the global therapeutic scenario for Vaginal Atrophy
(Atrophic Vaginitis).

- A review of the Vaginal Atrophy (Atrophic Vaginitis) products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging
from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.

- Coverage of the Vaginal Atrophy (Atrophic Vaginitis) pipeline on the
basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- News and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics
under development for Vaginal Atrophy (Atrophic Vaginitis).